Bone sarcoma statistics

Cases

New cases of bone sarcoma, 2014-2016 average, UK

Deaths

Deaths from bone sarcoma, 2016, UK.

Survival

Survive bone sarcoma for 10 or more years, 2009-2013, England

 

  • There are around 560 new bone sarcoma cases in the UK every year, that's around 2 every day (2014-2016).
  • Bone sarcoma is not among the 20 most common cancers in the UK, accounting for less than 1% of all new cancer cases (2016).
  • In females in the UK, bone sarcoma is not among the 20 most common cancers, with around 240 new cases in 2016.
  • In males in the UK, bone sarcoma is not among the 20 most common cancers, with around 280 new cases in 2016.
  • More than half (53%) of bone cancer cases in the UK each year are diagnosed in people aged 45 and over (2012-2014).
  • Incidence rates for bone sarcoma in the UK are highest in people aged 85+ (2012-2014).
  • Since the early 1990s, bone sarcoma incidence rates have increased by more than a tenth (14%) in the UK. This includes stable rates in males and an increase in females.
  • Over the last decade, bone sarcoma incidence rates have remained stable in the UK, for males and females separately and for both sexes combined.
  • Most bone sarcomas occur in the lower limbs.
  • Incidence rates for bone sarcoma are projected to fall by 5% in the UK between 2014 and 2035, to 1 case per 100,000 people by 2035.
  • Bone sarcoma in England is not associated with deprivation.
  • An estimated 69,100 people who had previously been diagnosed with bladder cancer were alive in the UK at the end of 2010.

See more in-depth bone sarcoma incidence statistics

  • There are around 350 bone sarcoma deaths in the UK every year, that's around 1 every day (2014-2016).
  • Bone sarcoma is not among the 20 most common causes of cancer death in the UK, accounting for less than 1% of all cancer deaths (2016).
  • In males in the UK, bone sarcoma is the 20th most common cause of cancer death, with around 220 deaths in 2016.
  • In females in the UK, bone sarcoma is not among the 20 most common causes of cancer death, with around 140 deaths in 2016.
  • Mortality rates for bone sarcoma in the UK are highest in people aged 90+ (2014-2016).
  • Since the early 1970s, bone sarcoma mortality rates have decreased by almost three-fifths (55%) in the UK. Rates in males have decreased by almost three-fifths (58%), and rates in females have decreased by almost three-fifths (55%).
  • Over the last decade, bone sarcoma mortality rates have remained stable in the UK. Rates in males have remained stable, and rates in females have remained stable.
  • Mortality rates for bone sarcoma are projected to fall by 23% in the UK between 2014 and 2035, to 1 death per 100,000 people by 2035.
  • Bone sarcoma in England is not associated with deprivation.

See more in-depth bone sarcoma mortality statistics

  • More than half (55%) of people diagnosed with bone sarcoma in England survive their disease for ten years or more (2009-2013).
  • More than 6 in 10 (62%) people diagnosed with bone sarcoma in England survive their disease for five years or more (2009-2013).
  • More than 8 in 10 (83%) people diagnosed with bone sarcoma in England survive their disease for one year or more (2009-2013).
  • Bone sarcoma 10-year survival in England is similar in men and women (2009-2013).
  • Bone sarcoma five-year survival in England in males is highest for those diagnosed at 50-59 years old and in females is highest for those diagnosed at 15-49 years old (2009-2013).
  • More than 7 in 10 people in England diagnosed with bone sarcoma aged 50-59 survive their disease for five years or more, compared with around 4 in 10 people diagnosed aged 70-89 (2009-2013).
  • Five-year relative survival for bone sarcoma in men is similar to the European average in England and Northern Ireland but below the European average in Scotland
  • Five-year relative survival for bone sarcoma in women is similar to the European average in England, Wales and Northern Ireland but below the European average in Scotland.

See more in-depth bone sarcoma survival statistics

  • A person’s risk of developing cancer depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
  • 1 in 1,616 UK males and 1 in 1,351 UK females will be diagnosed with bone sarcoma in their lifetime.

See more in-depth bone sarcoma risk statistics

  • ‘Two-week wait’ standards are met by all countries, ‘31-day wait’ is met by all but Northern Ireland and Wales, and ’62 day wait’ is not met by any country for sarcoma.
  • 9 in 10 patients had a ‘very good’ or ‘excellent’ patient experience.
  • Around 8 in 10 patients are given the name of their Clinical Nurse Specialist.

See more in-depth bone sarcoma diagnosis and treatment statistics

Want the key stats in the sections on this page as a document? or looking for a stats report of the in-depth stats? Use the print function at the bottom of any Cancer Stats page Share this page > Print or your browser options to print or save.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or

Donate online

We’re now on twitter.
Join the conversation and follow @CRUKHCPs for news, updates and opinion.

@CRUKHCPs

The University of Manchester are currently conducting a survey into healthcare professionals' and public attitudes towards sun exposure and vitamin D.

Take part

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.